Our UK clinicians can review your treatment history, previous dose and current health before advising on the next step
The STEP 1 trial used 2.4 mg as the target maintenance dose and achieved average weight loss of 14.9% of body weight over 68 weeks
But with two options, how do you know which is right for you
Reduction of atherosclerosis requires long-term treatment [53], hence longer trials are better suited to show a reduction in risk of myocardial infarction or other atherosclerotic complications of diabetes
By reducing glucagon levels, especially after meals, the medication prevents your liver from adding unnecessary glucose to your blood when levels are already elevated
La doctora Monereo cuenta con varios premios cientficos concedidos por la Academia Mdico Quirrgica, la Sociedad Espaola de Endocrinologa y Nutricin y la Sociedad Espaola para el estudio de la Obesidad en distintas ediciones